Luceco plc (LON:LUCE)
123.00
-5.00 (-3.91%)
Aug 1, 2025, 4:35 PM BST
Ligand Pharmaceuticals Market Cap
Luceco has a market cap or net worth of 187.58 million as of August 1, 2025. Its market cap has decreased by -28.03% in one year.
Market Cap
187.58M
Enterprise Value
262.48M
Revenue
242.50M
Ranking
n/a
PE Ratio
12.95
Stock Price
$123.00
Market Cap Chart
Since October 17, 2016, Luceco's market cap has decreased from 241.20M to 187.58M, a decrease of -22.23%. That is a compound annual growth rate of -2.82%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 187.58M | -5.28% |
Dec 31, 2024 | 198.03M | 3.47% |
Dec 29, 2023 | 191.38M | 26.86% |
Dec 30, 2022 | 150.86M | -71.82% |
Dec 31, 2021 | 535.38M | 35.69% |
Dec 31, 2020 | 394.56M | 100.03% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Oct 17, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Rolls-Royce Holdings | 89.38B |
RELX PLC | 71.14B |
BAE Systems | 54.29B |
Experian | 36.61B |
Ashtead Group | 21.52B |
International Consolidated Airlines Group | 17.68B |
Halma | 12.28B |
Rentokil Initial | 9.09B |